Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases

S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes

JM Borghardt, C Kloft, A Sharma - Canadian respiratory journal, 2018 - Wiley Online Library
The inhalation route is frequently used to administer drugs for the management of
respiratory diseases such as asthma or chronic obstructive pulmonary disease. Compared …

[HTML][HTML] Pulmonary delivery of biological drugs

W Liang, HW Pan, D Vllasaliu, JKW Lam - Pharmaceutics, 2020 - mdpi.com
In the last decade, biological drugs have rapidly proliferated and have now become an
important therapeutic modality. This is because of their high potency, high specificity and …

[HTML][HTML] Nanocellulose as sustainable biomaterials for drug delivery

S Das, B Ghosh, K Sarkar - Sensors International, 2022 - Elsevier
Nanocellulose (NC) has lately appeared as a member of the major promising “green”
materials, garnering great attentiveness due to it's unique features. Several new materials …

Nano-delivery to the lung-by inhalation or other routes and why nano when micro is largely sufficient?

V Forest, J Pourchez - Advanced Drug Delivery Reviews, 2022 - Elsevier
Respiratory diseases gather a wide range of disorders which are generally difficult to treat,
partly due to a poor delivery of drugs to the lung with adequate dose and minimum side …

Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications

R Kumar, P Mehta, KR Shankar, MAK Rajora… - Pharmaceutical …, 2022 - Springer
Purpose Respiratory disorders pose a major threat to the morbidity and mortality to public
health. Here we reviewed the nanotechnology based pulmonary drug delivery using …

Physical stability of dry powder inhaler formulations

N Shetty, D Cipolla, H Park, QT Zhou - Expert opinion on drug …, 2020 - Taylor & Francis
ABSTRACT Introduction: Dry powder inhalers (DPIs) are popular for pulmonary drug
delivery. Various techniques have been employed to produce inhalation drug particles and …

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections

HA Parray, S Shukla, R Perween, R Khatri… - Applied microbiology …, 2021 - Springer
The route of administration of a therapeutic agent has a substantial impact on its success.
Therapeutic antibodies are usually administered systemically, either directly by intravenous …

[HTML][HTML] Recent advances in aerosolised drug delivery

A Chandel, AK Goyal, G Ghosh, G Rath - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Pulmonary route is extensively studied for the diagnosis and treatment of pulmonary and
extra pulmonary disease conditions such as asthma, tuberculosis, emphysema, and …

[HTML][HTML] Oral inhalation for delivery of proteins and peptides to the lungs

E Fröhlich, S Salar-Behzadi - European Journal of Pharmaceutics and …, 2021 - Elsevier
Oral inhalation is the preferred route for delivery of small molecules to the lungs, because
high tissue levels can be achieved shortly after application. Biologics are mainly …